Mirum Pharmaceuticals, Inc. (MIRM) Insider Trading -- Recent Executive & Director Transactions

13 insiders reported 149 Form 4 transactions for Mirum Pharmaceuticals, Inc. (MIRM) over the past 18 months (most recent 2026-07-02). Recent activity: Howe Jolanda (SVP, GLOBAL CONTROLLER) Sell 2,721 shares, Howe Jolanda (SVP, GLOBAL CONTROLLER) Sell 2,594 shares, BJERKHOLT ERIC (CHIEF FINANCIAL OFFICER) Sell 2,258 shares, BJERKHOLT ERIC (CHIEF FINANCIAL OFFICER) Sell 1,175 shares, BJERKHOLT ERIC (CHIEF FINANCIAL OFFICER) Sell 1,567 shares. Source: SEC Form 4.

DateInsiderTitleTypeSharesValue
2026-07-02Howe JolandaSVP, GLOBAL CONTROLLERSell2,721$326,520
2026-06-18Howe JolandaSVP, GLOBAL CONTROLLERSell2,594$264,458
2026-06-09BJERKHOLT ERICCHIEF FINANCIAL OFFICERSell2,258$209,633
2026-06-09BJERKHOLT ERICCHIEF FINANCIAL OFFICERSell1,175$110,391
2026-06-09BJERKHOLT ERICCHIEF FINANCIAL OFFICERSell1,567$149,053
2026-06-09BJERKHOLT ERICCHIEF FINANCIAL OFFICERBuy2,393$63,391
2026-06-08Radovich PeterPRESIDENT AND COOBuy16,988$326,000
2026-06-02Ramasastry SairaDirectorSell3,977$397,700
2026-06-02Fischer LaurentDirectorBuy3,977$0
2026-06-02Ramasastry SairaDirectorBuy3,977$0
2026-06-02Peetz ChristopherCHIEF EXECUTIVE OFFICERBuy30,000$88,080
2026-06-02Cardon LonDirectorBuy3,977$0
2026-06-02Peetz ChristopherCHIEF EXECUTIVE OFFICERSell2,602$246,253
2026-06-02Peetz ChristopherCHIEF EXECUTIVE OFFICERSell16,595$1.6M
2026-06-02Peetz ChristopherCHIEF EXECUTIVE OFFICERSell6,926$665,935
2026-06-02Peetz ChristopherCHIEF EXECUTIVE OFFICERSell1,973$192,486
2026-06-02Peetz ChristopherCHIEF EXECUTIVE OFFICERSell1,021$100,262
2026-06-02Peetz ChristopherCHIEF EXECUTIVE OFFICERSell883$88,000
2026-06-02Walbert Timothy PDirectorBuy3,977$0
2026-05-18Ramasastry SairaDirectorBuy2,000$47,020
2026-05-18Ramasastry SairaDirectorSell2,000$218,940
2026-04-16Ramasastry SairaDirectorBuy2,000$47,020
2026-04-16Ramasastry SairaDirectorSell2,000$193,800
2026-03-17Howe JolandaSVP, GLOBAL CONTROLLERBuy6,000$0
2026-03-17Howe JolandaSVP, GLOBAL CONTROLLERBuy2,658$0

Source: SEC Form 4 filings · as of 2026-07-02